Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis (Q71623466)
Jump to navigation
Jump to search
scientific article published on 01 February 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis |
scientific article published on 01 February 1996 |
Statements
Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis (English)
Brod SA
1 February 1996